Butyrate-producing bacteria as pharmabiotics for inflammatory bowel disease

Gut

Volumn 62, Issue 12, 2013, Pages 1673-

  Marteau, Philippe ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; LACTIC ACID; N ACETYLGLUCOSAMINE; PREBIOTIC AGENT; SUGAR; URONIC ACID; VSL3;

BIFIDOBACTERIUM; BUTYRICICOCCUS PULLICAECORUM; COLITIS; ENTERITIS; FAECALIBACTERIUM PRAUSNITZII; FERMENTATION; HUMAN; INTESTINE FLORA; LACTOBACILLUS; NONHUMAN; NOTE; PRIORITY JOURNAL; ROSEBURIA;

BUTYRATE; COLONIC BACTERIA; INFLAMMATORY BOWEL DISEASE; PROBIOTICS;

ANIMALS; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GRAM-POSITIVE ENDOSPORE-FORMING RODS; HUMANS; MALE;

EID: 84887423043     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2012-304240     Document Type: Note

References (11)

1. Eeckhaut V, Machiels K, Perrier C, et al. Butyricicoccus pullicaecorum in inflammatory bowel disease. Gut 2013;62:1745-52.
2. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008;105:16731-6.
3. Ottman N, Smidt H, de Vos WM, et al. The function of our microbiota: who is out there and what do they do? Front Cell Infect Microbiol 2012;2:104.
4. Louis P, Young P, Holtrop G, et al. Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environ Microbiol 2010;12:304-14.
5. Belenguer A, Holtrop G, Duncan SH, et al. Rates of production and utilization of lactate by microbial communities from the human colon. FEMS Microbiol Ecol 2011;77:107-19.
6. Veiga P, Gallini CA, Beal C, et al. Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes. Proc Natl Acad Sci USA 2010;107:18132-7.
7. Duncan SH, Hold GL, Harmsen HJ, et al. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int J Syst Evol Microbiol 2002;52:2141-6.
8. Khan MT, Duncan SH, Stams AJ, et al. The gut anaerobe Faecalibacterium prausnitzii uses an extracellular electron shuttle to grow at oxic-anoxic interphases. ISME J 2012;6:1578-85.
9. Lopez-Siles M, Khan TM, Duncan SH, et al. Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth. Appl Environ Microbiol 2012;78:420-8.
10. Li RW, Wu S, Baldwin RL VI, et al. Perturbation dynamics of the rumen microbiota in response to exogenous butyrate. PLoS One 2012;7:e29392.
11. Jonkers D, Penders J, Masclee A, et al. Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients. Drugs 2012;72:803-23.